Turning new ideas into molecules that positively impact human health

News View all

Scientific research agreement between Foro delle Arti Srl, TES Pharma Srl and Fondo XGEN Venture

Apr 10, 2024

Laboratory 4.0 of a Biotech Company

Feb 21, 2023

TES Pharma Congratulates Intercept Pharmaceuticals on their Presentation of Phase 1 INT-787 Data at the AASLD Meeting and the Initiation of the Phase 2a FRESH Study in Patients with Severe Alcohol-Associated Hepatitis

Nov 8, 2022

Prof. Roberto Pellicciari Recipient of the EFMC Honorary Fellow Award.

Aug 18, 2021

Research and Development of NAD+ modulators for the Treatment of Hepato-Renal Dysfunction in COVID-19 Patients

Jul 15, 2021
Careers

We are always looking for talent and passion.

Find out if we have open positions.
Contacts

Don’t be shy!
Say Hi!

Send us an email.